Immune Therapeutics, Inc. (AIMT) Files An 8-K Other Events

Immune Therapeutics, Inc. (AIMT) Files An 8-K Other Events

Story continues below

Item 8.01 Other Events

On November 4, 2016, Immune Therapeutics, Inc. (the Company) paid
off its Promissory Note with JMJ Financial, disclosed in the
Current Form 8K/A filed by the Company on May 4, 2016, in the
principal amount of $656,250. These funds came from financing
provided by certain of the Companys current shareholders.

On November 14, 2016, the Company issued a press release
announcing its intent and efforts to restructure approximately
$1,700,000 of its current debt.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed herewith.

Exhibit No. Description
99.1 Press Release


About Immune Therapeutics, Inc. (AIMT)


An ad to help with our costs